# OXYBUTYNIN CHLORIDE
> **ANDA207329** · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL RX · Approved 2018-05-31
## Drug
- **FDA Application Number:** ANDA207329
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OXYBUTYNIN CHLORIDE
- **Generic name:** Oxybutynin Chloride
- **Active ingredients:** OXYBUTYNIN CHLORIDE
- **Dosage form:** GEL
- **Route:** TRANSDERMAL
- **Marketing status:** Discontinued
- **Sponsor:** CHARTWELL RX
- **First approval:** 2018-05-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207329)
---
*AI Analytics · CC0 1.0*